Braveheart Investment Group plc Appointment of representative to Board of Autins

RNS Number : 8098F

Braveheart Investment Group plc

26 September 2024

 

26 September 2024

 

Braveheart Investment Group plc

("Braveheart" the "Company" or the "Group")

 

Appointment of Braveheart representative to the Board of Autins Group plc

 

Braveheart Investment Group plc (AIM: BRH) announces that Dr Qu Li (Non-Executive Director of Braveheart) has been appointed as a Non-Executive Director to the Board of Autins Group plc ("Autins"). Braveheart holds 26.95% per cent. of the issued share capital of Autins and Dr Qu Li has been appointed to act as a representative of Braveheart on the Board of Autins.

 

As part of Dr Qu Li's appointment to the Board of Autins, Braveheart, Autins, and the nominated adviser to Autins have all entered into a relationship agreement (the "Relationship Agreement"). The Relationship Agreement is to ensure that Autins is capable of carrying on its business independently of Braveheart at all times, and that the costs associated with Qu Li's appointment and tenure as a Director of Autins will be borne by Braveheart.

 

Trevor Brown, CEO of Braveheart, commented:

"It is three years since we first invested in Autins. Over the ensuing months, as we got to know Autins and its Board, we became convinced that a bright future lay ahead for the company as conditions in the global automative market normalized after the shock of COVID. Qu Li has a deep knowledge of the sector built over many years and we believe that her appointment will prove beneficial to both Boards."

 

Braveheart Investment Group plc	Tel: [phone]
Trevor Brown, Chief Executive Officer Viv Hallam, Executive Director
Allenby Capital Limited (Nominated Adviser and Joint Broker)	Tel: [phone]
James Reeve / George Payne
Peterhouse Capital Limited (Joint Broker)	Tel: [phone]
Duncan Vasey / Lucy Williams

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

BOAEAPNKADLLEEA